A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.
Dhillo. Waljit S WS; Small. Caroline J CJ; Seal. Leighton J LJ; Kim. Min-Seon MS; Stanley. Sarah A S...
The study shows that a long‑acting version of alpha‑MSH (similar to melanotan‑I) and the natural antagonist AgRP both trigger the brain's stress‑hormone system in male rats, raising ACTH and cortisol levels. Combining the two doesn't make the effect bigger, hinting they might work through a shared or another unknown receptor.
Biaggi. M H MH; Pinheiro. T J TJ; Watts. A A; Lamy-Freund. M T MT
The study shows that melanotan‑I (a synthetic version of alpha‑MSH) sticks to negatively charged cell‑like membranes and makes the fat‑chain parts of the membrane move less, while it does nothing to neutral membranes. The more powerful version of the peptide does this even more strongly, likely because it binds tighter or goes deeper into the membrane. This is basic science, not a direct dosing guide, but it hints that melanotan‑I can affect membrane fluidity in certain tissues.
Haskell-Luevano. C C; Miwa. H H; Dickinson. C C; Hruby. V J VJ; Yamada. T T; Gantz. I I
This study measured how strongly the skin‑pigment hormone alpha‑MSH and its stronger lab‑made versions (MT‑I and MT‑II) stick to and activate the human MC1R receptor, which controls melanin production. The results show that the synthetic peptides bind and trigger the receptor at much lower concentrations than the natural hormone, confirming they are far more potent.
Castrucci. A M AM; Hadley. M E ME; Sawyer. T K TK; Hruby. V J VJ
The study shows that natural melanotropins (alpha‑ and beta‑MSH) are quickly broken down by enzymes in blood, especially in frogs, while the synthetic version used in melanotan‑I ([Nle4, D‑Phe7]‑alpha‑MSH) is highly resistant to this breakdown. This means the synthetic peptide stays active longer in the body, making it more useful for research or self‑experiments compared to the natural hormones.
Ramírez. D D; Saba. J J; Carniglia. L L; Durand. D D; Lasaga. M M; Caruso. C C
The study shows that activating the brain's MC4R receptor with an alpha‑MSH‑like peptide (similar to melanotan‑I) can raise levels of BDNF, a protein that supports brain health, through a specific ERK‑cFos signaling chain. This was demonstrated in rat brain cells and in live rats, but no human data or dosing guidelines are provided.
Hunt. G G; Donatien. P D PD; Lunec. J J; Todd. C C; Kyne. S S; Thody. A J AJ
The study shows that human skin cells (melanocytes) do respond to melanocyte‑stimulating hormone (MSH) peptides like melanotan‑I when grown without certain lab chemicals, leading to more melanin and enzyme activity. Both natural alpha‑MSH and the synthetic version (NDP‑MSH) work equally well, and even ACTH can boost melanin at low levels. This confirms the basic idea that melanotan‑I can tan skin by directly activating melanocytes, but the work was done in a dish, not on people.
Donatien. P D PD; Hunt. G G; Pieron. C C; Lunec. J J; Taïeb. A A; Thody. A J AJ
The study shows that human skin cells that make pigment (melanocytes) have specific receptors for alpha‑MSH, the natural hormone that melanotan‑I mimics, and that these receptors can be increased or decreased by certain chemicals. This confirms the basic target for melanotan‑I is present in human cells, but the work was done in a dish, not in living people.
Hunt. G G; Todd. C C; Cresswell. J E JE; Thody. A J AJ
The study shows that alpha‑MSH and its stronger analogue can make human skin cells turn more dendritic and boost the enzyme that makes melanin, leading to more pigment, but the effect varies between cell samples.
Chaturvedi. D N DN; Knittel. J J JJ; Hruby. V J VJ; Castrucci. A M AM; Hadley. M E ME
Scientists attached a biotin tag to a super‑potent version of the tanning peptide melanotan‑I and found it works just as well as the original but stays active longer in lab skin tests and resists enzyme breakdown.
Dorr. R T RT; Dawson. B V BV; al-Obeidi. F F; Hadley. M E ME; Levine. N N; Hruby. V J VJ
In mouse tests, a super‑potent melanin‑boosting peptide (NDP‑MSH) showed no major organ damage or hormone changes even at high doses for up to three months, though a small rise in blood fats and platelets was seen with weekly dosing. Skin‑based delivery worked, but only a tiny fraction of the drug actually passed through the skin, meaning injections are far more effective. The data suggest the compound is likely safe enough to move into early human trials, but users should watch blood lipids and platelets if they plan long‑term use.
The study surveyed people on an online forum who use melanotan‑I or II to get a tan, asking why they use it, how they get it, and if they’ll keep using it. It shows most users are motivated by cosmetic tanning, find the drugs easy to buy online, have some safety concerns, and many plan to continue despite the lack of regulation.
Sawyer. T K TK; Sanfilippo. P J PJ; Hruby. V J VJ; Engel. M H MH; Heward. C B CB; Burnett. J B JB; H...
Scientists made a version of the skin‑darkening hormone alpha‑MSH that’s much stronger and lasts longer because they swapped two building blocks. This new peptide, called [Nle4,D-Phe7]-alpha‑MSH (often sold as melanotan‑I), is about 26‑times more active in lab tests and resists breakdown by blood enzymes, so it could work at lower doses and stay effective longer. However, the study only looked at frog skin and mouse cells, not humans, so real‑world safety and benefits for things like weight loss or performance are still unknown.
Bazzani. C C; Guarini. S S; Botticelli. A R AR; Zaffe. D D; Tomasi. A A; Bini. A A; Cainazzo. M M MM...
In rats, giving melanocortin peptides (similar to the skin‑tanning peptide melanotan‑I) right after a heart attack reduced dangerous heart rhythms, lowered death rates, cut the spike in harmful free radicals, and helped more heart tissue stay healthy. The effect was stronger with higher doses, but the study was done only in animals, not people.
Mykicki. Nadine N; Herrmann. Alexander M AM; Schwab. Nicholas N; Deenen. René R; Sparwasser. Ti...
A study found that melanotan‑I (NDP‑MSH), a drug that activates the melanocortin‑1 receptor, can calm the immune system, protect the blood‑brain barrier, and keep neurons alive in mouse models of multiple sclerosis. The peptide helped regulatory T cells work better and stopped harmful immune cells from entering the brain, leading to less damage and better nerve function.
Abdel Malek. Z A ZA; Kreutzfeld. K L KL; Marwan. M M MM; Hadley. M E ME; Hruby. V J VJ; Wilkes. B C...
The study shows that specially modified versions of the tanning peptide (melanotan‑I analogues) are far more powerful at turning on the melanin‑making enzyme in mouse melanoma cells and keep it active for days after the peptide is gone. This suggests they could give a longer‑lasting tan with less frequent dosing, but the work was done in cancer cells in a dish, not in people, so the real‑world relevance and safety are unclear.
The study shows that calcium ions are important for how skin cells respond to alpha‑MSH (the natural hormone that melanotan‑I mimics). Changing calcium levels changes the strength of the response, and calcium is needed both for the hormone to bind its receptor and for the signal to travel inside the cell.
The study shows that the synthetic peptide melanotan‑I (NDP‑MSH) binds to its skin‑cell receptor, gets pulled inside the cell, and then the receptor stays down for days, meaning the cells become less responsive. Some receptors stay resistant, but overall the effect is a long‑lasting drop in receptor numbers.
Hadley. M E ME; Wood. S H SH; Lemus-Wilson. A M AM; Dawson. B V BV; Levine. N N; Dorr. R T RT; Hruby...
The study shows that a very potent version of the tanning hormone (a melanotropin similar to melanotan‑I) can be absorbed through the skin of mice, leading to increased dark pigment (eumelanin) in hair follicles both where the cream was applied and elsewhere on the body. This proves the peptide can get into the bloodstream via a cream, not just by injection, and hints that a similar approach might work in people for treating light‑skin conditions.
Joseph. Christine G CG; Wilczynski. Andrzej A; Holder. Jerry R JR; Xiang. Zhimin Z; Bauzo. Rayna M R...
Scientists swapped parts of a known tanning peptide (NDP‑MSH) with pieces from a protein that normally blocks the same receptors. Surprisingly, the new hybrid still activated the receptors in mice, and one version was extremely good at hitting only the MC1R receptor, which is the one that makes skin tan, while ignoring the other receptors that affect appetite and metabolism.
Gehlsen. K R KR; Hadley. M E ME; Levine. N N; Ray. C G CG; Hendrix. M J MJ
In mice with a type of skin cancer, giving the super‑potent melanin‑stimulating peptide (the same kind used in melanotan‑I) did not make the tumors grow bigger, spread to the lungs, or become more invasive. Survival was the same as in untreated mice.